nVent Electric PLC (NVT)vsVertex Pharmaceuticals Inc (VRTX)
NVT
nVent Electric PLC
$116.98
-1.23%
INDUSTRIALS · Cap: $20.31B
VRTX
Vertex Pharmaceuticals Inc
$433.07
-4.56%
HEALTHCARE · Cap: $113.95B
Smart Verdict
WallStSmart Research — data-driven comparison
Vertex Pharmaceuticals Inc generates 208% more annual revenue ($12.00B vs $3.89B). VRTX leads profitability with a 32.9% profit margin vs 18.2%. NVT appears more attractively valued with a PEG of 1.57. NVT earns a higher WallStSmart Score of 67/100 (B-).
NVT
Strong Buy67
out of 100
Grade: B-
VRTX
Strong Buy66
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+10.8%
Fair Value
$126.36
Current Price
$116.98
$9.38 discount
Margin of Safety
+39.5%
Fair Value
$716.04
Current Price
$433.07
$282.97 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Revenue surging 41.8% year-over-year
Keeps 33 of every $100 in revenue as profit
Strong operational efficiency at 39.6%
Safe zone — low bankruptcy risk
Large-cap with strong market position
Every $100 of equity generates 23 in profit
Conservative balance sheet, low leverage
Areas to Watch
Expensive relative to growth rate
Premium valuation, high expectations priced in
Expensive relative to growth rate
Moderate valuation
Weak financial health signals
Comparative Analysis Report
WallStSmart ResearchBull Case : NVT
The strongest argument for NVT centers on Revenue Growth. Profitability is solid with margins at 18.2% and operating margin at 16.2%. Revenue growth of 41.8% demonstrates continued momentum.
Bull Case : VRTX
The strongest argument for VRTX centers on Profit Margin, Operating Margin, Altman Z-Score. Profitability is solid with margins at 32.9% and operating margin at 39.6%.
Bear Case : NVT
The primary concerns for NVT are PEG Ratio, P/E Ratio. A P/E of 46.5x leaves little room for execution misses.
Bear Case : VRTX
The primary concerns for VRTX are PEG Ratio, P/E Ratio, Piotroski F-Score.
Key Dynamics to Monitor
NVT profiles as a growth stock while VRTX is a mature play — different risk/reward profiles.
NVT carries more volatility with a beta of 1.30 — expect wider price swings.
NVT is growing revenue faster at 41.8% — sustainability is the question.
VRTX generates stronger free cash flow (349M), providing more financial flexibility.
Bottom Line
NVT scores higher overall (67/100 vs 66/100), backed by strong 18.2% margins and 41.8% revenue growth. VRTX offers better value entry with a 39.5% margin of safety. Both earn "Strong Buy" and "Strong Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
nVent Electric PLC
INDUSTRIALS · ELECTRICAL EQUIPMENT & PARTS · USA
nVent Electric plc designs, manufactures, markets, installs and services electrical connection and protection products in the United States, Canada, Western and Eastern Europe included in the European Union, China, Eastern Europe not included in the European Union, America Latin, Middle East, Southeast Asia, Australia and Japan. The company is headquartered in London, the United Kingdom.
Vertex Pharmaceuticals Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Vertex Pharmaceuticals, Inc. is an American biopharmaceutical company based in Boston, Massachusetts.
Compare with Other ELECTRICAL EQUIPMENT & PARTS Stocks
Want to dig deeper into these stocks?